Table 1 Characteristics of patients in the training cohort and validation cohort
|  | Training cohort (n = 10,474) | Validation cohort a (n = 15,899) | Validation cohort b (n = 17,283) |
|---|---|---|---|
Age | Â | Â | Â |
mean (SD) | 69.2 (20.0) | 71.3 (16.4) | 70.7 (17.2) |
Gender | Â | Â | Â |
Male | 2,554 (50.4%) | 8,245 (51.9%) | 9,194 (53.2%) |
Female | 2,517 (49.6%) | 7,654 (49.1%) | 8,089 (46.8%) |
DNR | Â | Â | Â |
Yes | 950 (18.7%) | 3,406 (21.4%) | 3,650 (21.1%) |
No | 4,121 (81.3%) | 12,493 (78.6%) | 13,633 (78.9%) |
Disease | Â | Â | Â |
Trauma | 1,128 (10.8%) | 3,441 (21.6%) | 3,110 (18.0%) |
Non-trauma | 9,346 (89.2%) | 12,458 (78.4%) | 14,173 (82.0%) |
Cancer | 2,633 (25.1%) | 3,145 (19.8%) | 3,616 (20.9%) |
Non-cancer | 7,841 (74.9%) | 12,754 (80.2%) | 13,667 (79.1%) |
SQ | Â | Â | 1 |
Yes | 8,148 (77.8%) | 13,809 (86.8%) | 3,158 (76.1%) |
No | 2,326 (22.2%) | 2,090 (13.2%) | 4,125 (23.9%) |
qSOFA | Â | Â | Â |
< 2 | 4,705 (92.8%) | 14,935 (93.9%) | 16,631 (96.2%) |
≥ 2 | 366 (7.2%) | 964 (6.1%) | 652 (3.8%) |
PSS | Â | Â | Â |
≥ 2 | 1,609 (31.7%) | 4,863 (30.6%) | 5,846 (33.8%) |
< 2 | 3,462 (68.3%) | 11,036 (69.4%) | 11,437 (66.2%) |
Death | Â | Â | Â |
Yes | 3,556 (34.0%) | 6,748 (42.4%) | 6,890 (39.9%) |
No | 6,918 (66.1%) | 9,151 (57.6%) | 10,393 (50.1%) |